Pathological pooling of RBCs within the heart muscle is known to take place in the setting of reperfused myocardial infarction. 19, 20 Although the endothelial cells have a higher
S pecific pathological conditions can mediate increased tissue levels of iron in a number of organs, including the brain, [1] [2] [3] liver, 4, 5 and heart. 6, 7 In these settings, biodegradation of heme, harbored by red blood cells (RBCs) , is considered to be the most significant source of iron. In the heart, chronic deposition of iron has been known to occur predominantly in hemochromatosis, 8, 9 in blood transfusion therapy for thalassemia major, 10, 11 and in sickle-cell anemia. 12 Abnormal accumulation of iron in the heart has been associated with poor cardiac function 7, [13] [14] [15] and conduction abnormalities.
tolerance for ischemia than cardiomyocytes, prolonged periods (>90 minutes) of no-flow ischemia in myocardial tissue lead to oncosis (cell death) of the vascular endothelium and thus to a breakdown of the microvascular barrier. 21 Therefore, a delayed reinstitution of epicardial coronary blood flow after acute coronary occlusion may lead to the extravasation of erythrocytes (hemorrhage) with severe consequences for regional perfusion. In fact, gross bleeding within the heart muscle is a frequently encountered hallmark of large myocardial infarctions. [22] [23] [24] [25] The observed correlate with respect to blood flow is known as no-reflow. 26, 27 Although the prognostic significance of large infarctions with microvascular obstructions (MVOs) has been well studied, [28] [29] [30] interest in the clinical consequences of intramyocardial hemorrhage has been increasing only recently. Hemorrhagic infarctions have been shown to be associated with adverse left ventricular (LV) remodeling, [31] [32] [33] [34] late arrhythmogenic risk, 35 and major adverse cardiovascular events. 36 However, the long-term fate of acute reperfused myocardial hemorrhage and its effects on the heart remain largely unexplored. In this study, we investigated whether (1) acute reperfusion hemorrhage specifically imparts compositional changes in chronically infarcted myocardial tissue and (2) if so, whether such compositional differences mediate prolonged inflammation in the chronic phase of infarction. In particular, we hypothesized that acute reperfusion myocardial hemorrhage leads to chronic iron depositions localized within the infarcted territories in the chronic phase. We tested this hypothesis using cardiovascular magnetic resonance (CMR) imaging in a pilot patient population who underwent successful coronary revascularization for first ST-segment-elevation myocardial infarction. Furthermore, using a proof-of-concept canine model subjected to ischemia-reperfusion (I/R) injury, we validated our findings in humans. Subsequently, we tested the hypothesis whether reperfusion-induced chronic iron deposition leads to a prolonged inflammatory activity in the chronic phase of infarction. We tested this hypothesis by histopathologic analysis of chronically infarcted canine myocardium with a history of acute reperfusion hemorrhage.
Methods

Patient Selection and CMR Imaging Studies
Patients were enrolled after providing informed consent and studied according to the protocols approved by the Institutional Review Board at the Foothills Medical Center (Calgary, AB, Canada). Patients with acute ST-segment-elevation myocardial infarction (n=15; 3 women; mean age=58±8 years) meeting the American Heart Association diagnostic criteria were enrolled in the study, only if successful percutaneous coronary intervention (PCI) (Thrombolysis in Myocardial Infarction flow grade 3 post-PCI) was performed within 12 hours of the onset of symptoms. Patients were excluded from the study if they had previous myocardial infarctions or had contraindications for a CMR study. All enrolled patients underwent CMR 3 days after PCI and again at 6 months after initial enrollment in a clinical 1.5-T MRI system (MAGNETOM Avanto, Siemens Medical Solutions, Erlangen, Germany).
Cine steady-state free precession 37 ( LGE; inversion-recovery prepared fast low-angle shot; TR =1 R-R interval; TE=3.32 milliseconds; BW=235 Hz/pixel, 1.6×1.6 mm 2 ) images of contiguous short-axis sections of the LV along with 2-, 3-, and 4-chamber long-axis views of the heart were acquired. Commonly used imaging parameters were slice thickness of 10 mm and number of averages of 1. Note that our TE selection for the T2*-weighted acquisitions was determined with the goal of optimizing image quality and T2* sensitivity. Although a slice thickness of 6 to 8 mm and TR of 2 R-R intervals are used as standard for LGE images, we chose to acquire thicker slices at a TR of 1 R-R interval primarily to reduce the breathhold time for the patients. The heart rates of the patients in our study were sufficiently low that excellent contrast between the remote and infarcted myocardium could still be achieved.
Proof-of-Concept Studies in Canines
Animal Preparation and CMR Studies
Canines (n=23; 20-25 kg) were studied according to the protocols approved by the Institutional Animal Care and Use Committee of Northwestern University (Chicago, IL). Animals were subjected to I/R injury (Infarct group; n=20) by fully occluding the left anterior descending artery ( Figure I in the online-only Data Supplement) for 3 hours followed by reperfusion. CMR studies were performed on a clinical 1.5-T MRI system (MAGNETOM Avanto, Siemens Medical Solutions, Erlangen, Germany) on days 3 (acute) and 56 (chronic) after I/R injury. Sham-operated animals (Sham group; n=3) underwent CMR at similar time points. Cine steady-state free precession (TR/TE=3.5/1.75 milliseconds; flip angle=70°; 25-30 cardiac phases and BW=930 Hz/pixel), T2*-weighted (TR=240 milliseconds; 6 TEs=3.4-18.4 milliseconds with ΔTE=3.0 milliseconds; flip angle=12° and BW=566 Hz/pixel), and LGE images (inversionrecovery prepared steady-state free precession; TR/TE=3.5/1.75 milliseconds; flip angle=40° and BW=1002 Hz/pixel) of contiguous short-axis sections covering the entire LV and the 3 long-axis views were acquired at mid-diastole. As in patient studies, the TE selection for the T2*-weighted acquisitions was determined with the goal of optimizing image quality and T2* sensitivity. Commonly used imaging parameters were in-plane resolution of 1.3×1.3 mm 2 , slice thickness of 8 mm, and number of averages of 1. On day 56, animals were euthanized, and their hearts were excised and cut into roughly 1-cmthick slices. Ex vivo 2D T2*-weighted and LGE images of each slice were acquired using the in vivo imaging parameters.
Isolation of Tissue Samples and Histopathology
The freshly excised heart from each animal was sliced and stained with triphenyl tetrazolium chloride 41 (TTC) to histochemically validate irreversible myocardial damage and to delineate the infarcted territories from viable myocardium. Remote, hemorrhagic (Hemo+), and nonhemorrhagic (Hemo−) myocardium were identified on the basis of ex vivo CMR and TTC staining as explained in the Image Analysis section. Hemo+ and Hemo− infarcts were cut out into 0.5-to 0.8-cm 3 samples from densely infarcted areas. Similarly, from each slice, at least 2 samples of TTC-stained viable myocardium were isolated (remote). From each sham slice, at least 2 samples of TTCstained normal myocardium were isolated. Contiguous 5-µm sections were obtained from a representative sample of each of the Hemo+, Hemo−, remote, and sham groups from every animal. These sections were stained with hematoxylin and eosin stain, Masson Trichrome stain for fibrosis, Perls stain for iron, and monoclonal antibody Mac387 stain (Dako, Carpinteria, CA) for newly recruited macrophages, and sections were imaged at ×100 and ×400 magnifications. 
Inductively Coupled Plasma Mass Spectrometry
Image Analysis
Image analyses were performed using cmr 42 (Circle Cardiovascular Imaging Inc, Canada; Figure II in the online-only Data Supplement). T2* maps were constructed by fitting the multiecho T2*-weighted images to a monoexponential decay ( Figure III in the online-only Data Supplement). For the in vivo CMR images from both patients and animals, remote myocardium was defined as the region showing no hyperintensity on LGE images. A reference region of interest was drawn in remote myocardium on both LGE and T2*-weighted images. Infarcted myocardium was defined as the hyperintense region on LGE images with mean signal intensity at least 5 SDs above that of the reference region of interest. 42 On the acute phase LGE images, hypointense regions of MVO were manually included as part of the infarcted myocardium. Hemo+ myocardium was defined as infarcted myocardium with hypointense signal on the T2*-weighted image acquired at the last echo (TE=13.7 milliseconds for patients and 18.4 milliseconds for animals) with mean signal intensity of at least 2 SDs below that of the reference region of interest. 39, 43 The last echo was used to ensure adequate T2* weighting. The different thresholds used for the detection of infarcted territories and hemorrhagic zones have been previously described by others 39, 42, 43 and are a reflection of the sensitivity of the T1 and T2* approaches used for identifying the respective markers (Gd for T1 and byproducts of heme for T2*). Hemo− myocardium was defined as the region positive for infarction on LGE images but negative for hemorrhage on the corresponding T2*-weighted images. For the in vivo T2*-weighted images, care was taken not to include inferolateral LV segments affected by offresonance artifacts 44 arising from the susceptibility shifts at the heartlung interface.
For the ex vivo CMR images from animals, remote myocardium of a given slice was defined as the section of the tissue showing no hyperintensity on ex vivo LGE images and stained brick red by TTC. Hemo+ and Hemo− myocardium were similarly identified on the basis of ex vivo T2*-weighted, and LGE images were identified on the basis of threshold analysis used for in vivo image analysis. In vivo and ex vivo T2* values for Hemo+, Hemo−, remote, and sham groups were measured on per-slice (T2* slice ) basis and whole-heart (T2* heart ) basis for each animal.
LV mass, end-diastolic volume (EDV), end-systolic volume (ESV), ejection fraction (EF), and end-diastolic sphericity index (EDSI) were calculated for both patients and canines from the respective cine steady state free precession images. All measurements were normalized to the body surface area. Infarct volume (%Infarct) and hemorrhage volume (%Hemo) were calculated with respect to the total LV myocardial volume.
Statistical Analysis
Statistical analyses were performed using STATA 10.1 (StataCorp). A 2-tailed value of P <0.05 was considered to be statistically significant for all statistical analyses in both patients and canines. For patients, mixed-model linear regression with Bonferroni corrections (P<0.0001) was used to compare in vivo T2* slice among the Hemo+, Hemo−, and remote groups. We tested the null hypothesis that there was no difference in in vivo T2* slice among the 3 different groups. Patients were entered as random effects, whereas slices from each heart were nested in the analysis to account for repeated measurements from a single heart (or myocardial slice).
11
Changes in in vivo T2* heart values between day 3 and 6 months were evaluated using a paired t test. The relationship between mean in vivo T2* heart from acute and chronic phase CMR studies was also evaluated.
LV mass, EDV, ESV, EF, EDSI, and %Infarct were compared between patients with Hemo+ and Hemo− infarctions using 2-sample t test, and between acute (day 3) and chronic (month 6) phases of infarction post-PCI using paired t test. Among the patients with Hemo+ infarctions, %Hemo was compared between day 3 and month 6 post-PCI using paired t test. Simple and multivariable regression analyses were performed to determine whether %Infarct and %Hemo volumes were predictors of LV remodeling parameters (EDV, EF, ESV, and EDSI) in the chronic phase at 6 months post-PCI.
For animals, in vivo T2* slice , ex vivo T2* slice , and [Fe] sample were compared among the Hemo+, Hemo−, remote, and sham groups using mixed-model linear regression with Bonferroni corrections (P<0.0001). We tested the null hypothesis that there was no difference among the 4 different groups for each parameter of interest. Canines were entered as random effects, whereas samples from each heart (or myocardial slice) were nested in the analysis to account for repeated measurements from a single heart (or myocardial slice). Paired t test was used to compare in vivo T2* heart values obtained from CMR studies on days 3 and 56. The relationship between in vivo T2* heart (from days 3 and 56 CMR studies) and the corresponding ex vivo T2* heart was evaluated. Similarly, the relationship between log(ex vivo T2* heart ) and −log([Fe] heart ) was evaluated.
LV mass, EDV, ESV, EF, EDSI, %Infarct, and %Hemo were compared in canines between acute (day 3) and chronic (day 56) phases postreperfusion using paired t test. Simple and multivariable regression analyses were performed to determine whether %Infarct and %Hemo were predictors of LV remodeling (EDV, ESV, EF, and EDSI) at in the chronic phase (day 56) postreperfusion.
Results
Chronic Iron Deposition in Humans After Hemorrhagic Myocardial Infarction
In the acute phase (day 3), 11 patients were identified positive for hemorrhagic myocardial infarction (Table 1; regions: 5 lateral, 3 anteroseptal, and 3 inferior lateral), whereas 4 patients had nonhemorrhagic infarctions (2 lateral, 1 anteroseptal, and 1 inferior lateral). A representative set of CMR images acquired on day 3 and 6 months post-PCI from a patient with hemorrhagic infarction is shown in Figure 1A . Relative to the remote myocardium, significant T2* decreases were observed in the acute infarct territories in 11 patients and remained reduced on the 6-month follow-up images. On day 3 CMR, all the imaging slices that showed significant T2* losses within the infarcted territories also showed MVO on the corresponding LGE images. In the 4 patients negative for hemorrhage on day 3, T2* values of the infarct zones were similar to the remote territories on the 6-month followup scans. Comparison of in vivo T2* slice among the different groups obtained during the acute and chronic phases of infarction showed that T2* of Hemo+ (44 slices from acute phase and 40 slices from chronic phase) was significantly lower than those of the other groups (P<0.0001; Figure 1B ), whereas T2* slice values of remote (70 slices from acute phase and 64 slices from chronic phase) and Hemo− (26 slices from acute phase and 24 slices from chronic phase) tissue groups were not different (P=0.51). T2* heart values of remote, Hemo−, and Hemo+ tissues did not differ significantly between acute and chronic phases (remote: P=0.21; Hemo−: P=0.12; Hemo+: P=0. 19 ). On average, we observed ≈40% reduction in T2* of Hemo+ regions compared with the control regions, remote, and Hemo−. In vivo T2* heart values from these tissues on day 3 and month 6, regressed against one another, showed a strong correlation (y=0.79x+5.85, where y is T2* heart at month 6, and x is T2* heart on day 3; R 2 =0.7; P<0.001; Figure 1C ).
Morphological and Functional Characteristics of LV in Patients Post-PCI
Compared with the patients with Hemo− infarctions, patients with Hemo+ infarctions had larger LV mass index, larger %Infarct volume, larger EDV, larger ESV, and lower EF at both acute (day 3) and chronic (month 6) phases post-PCI (Table 1 ; P<0.001 for all cases). There was no significant difference between the EDSI of patients with Hemo+ and Hemo− infarctions at 3 days post-PCI (P=0.31). However, EDSI of patients with Hemo+ infarctions was significantly higher than that of patients with Hemo− infarctions at 6 months post-PCI (P<0.001).
Between the acute and chronic phases, LV mass index and %Infarct volume decreased in patients with both Hemo+ and Hemo− infarctions (P<0.001 for all cases). Patients with Hemo− infarctions had no significant difference in EDV between day 3 and month 6 post-PCI (P=0.14), but there was a significant decrease in ESV (P=0.024) and a significant However, a separate multivariable regression analysis showed that only %Infarct volume measured at 6 months was a significant predictor of the change in EDSI between the acute and chronic phases (β=0.87; P=0.015). However, neither %Infarct volume nor %Hemo volume measured at both 3 days and 6 months post-PCI could predict changes in other LV remodeling parameters (EDV, ESV, and EF).
Acute Reperfusion Hemorrhage Leads to Chronic Iron Deposition in Canine Hearts
Cardiovascular Magnetic Resonance
Four animals from the infarcted group died within the first 2 hours of establishing reperfusion despite rescue efforts. In 2 animals, reperfusion was not established because of occluder failure. These animals were excluded from the study. The remaining 14 animals from the infarcted group sustained acute hemorrhagic infarctions as observed from the acute phase (day 3) CMR studies. Of these 14 animals, 3 animals were euthanized on day 3 for gross and histopathologic analysis of acute hemorrhagic infarctions. The remaining 11 animals with I/R injury were allowed to recover into a chronic phase and underwent CMR on day 56 postreperfusion. Subsequently, the animals were euthanized, and tissue analysis was performed. The 3 sham animals survived the entire duration of the study and successfully underwent CMR studies on days 3 and 56, on which the animals were euthanized and their hearts were analyzed. All the data reported from canines in this article (except the histology from acute myocardial infarction) are from the Sham group and animals surviving I/R injury to day 56.
Representative T2* maps and LGE images obtained from the acute phase (day 3), chronic phase (day 56), and ex vivo CMR studies (posteuthanasia on day 56) are shown in Figure 2 . Significant T2* decreases were observable within the infarcted territories in both the acute and chronic phases. Consistent with the patient studies, all the imaging slices on day 3 CMR that showed significant T2* losses within the infarcted territories also showed MVO on the corresponding LGE images. In vivo T2* slice values of Hemo+ territories (33 slices from acute phase and 31 slices from chronic phase) were significantly lower than those of the control groups at acute and chronic phases (P<0.0001 for both the cases; Figure 3A) . In vivo T2* slice values between Hemo− (23 slices from acute phase and 22 slices from chronic phase), remote (56 slices from acute phase and 53 slices from chronic phase), and sham (20 slices from both acute and chronic phases) groups were not different (remote versus sham: P=0.72; remote versus Hemo−: P=0.81) during both acute and chronic phases. No significant differences in in vivo T2* heart of Hemo−, remote, and sham territories were observed between acute and chronic phases (Hemo−: P=0.34; remote: P=0. 35 ; sham: P=0.26), but there was a small but significant decrease in in vivo T2* heart of Hemo+ territories in the chronic phase at P<0.05 level (P=0.03).
Comparison of mean ex vivo T2* slice among the different groups showed that only Hemo+ was significantly different from the control groups (P<0.0001; Figure 3B ). In vivo T2* heart values from these tissues on days 3 and 56, regressed individually against ex vivo T2* heart estimates, showed very strong correlations (y1=0.52x+16.18, R 2 =0.7; y2=0.56x+14.89, R 2 =0.9, where y1 is in vivo T2* heart on day 3, y2 is in vivo T2* heart on day 56, and x is ex vivo T2* heart ; P<0.001 for both cases; Figure 3C ). Similar to patients, on average, a 40% decrease in T2* was observed in regions of hemorrhagic infarctions compared with the control groups at 1.5T.
Histology
Representative histopathologic images of acute and chronic myocardial infarctions are shown in Figure 4 . Myocardial tissue analysis from animals euthanized on day 3 showed that I/R injury showed large myocardial infarctions evidenced by positive staining in TTC with internal bleeding at the core of the myocardial infarction ( Figure 4A ). Hematoxylin and eosin stains confirmed the tissue damage and morphological alterations in regions positive for infarction in TTC staining ( Figure 4A1 ). Hematoxylin and eosin stains also showed extravasation of RBCs into the interstitial space of the infarcted regions. Perls stains confirmed a local accumulation of iron within the infarcted areas ( Figure 4A3 ). Hemorrhagic infarctions in the chronic phase on TTC staining showed a visually evident yellowish-brown discoloration extending from the endocardial border to the core of the infarct ( Figure 4B ). Hematoxylin and eosin stains from the same tissue ( Figure 4B1 ) confirmed the presence of extensive tissue damage, and Masson Trichrome stain ( Figure 4B2 ) showed extensive collagenous tissue in the infarct zone. Perls stain of corresponding myocardial territories showed a persistent and heterogeneous deposition of iron within the infarction ( Figure 4B3 ). Iron was also found to be interspread among viable cells and intact blood vessels (lower inset of Figure 4B3 obtained from infarct border). For a given stain, remote (noninfarcted) tissue sections were similar between acute and chronic phases but were markedly different in infarcted tissue sections ( Figure 4A4-4A6 and 4B4-4B6) . The monoclonal antibody Mac387 staining of chronic infarctions showed that newly recruited macrophages were highly colocalized with the chronic iron deposits identified on Perls stain ( Figure 5 ). Minimal or no macrophages were observed in the infarcted myocardial territories that were devoid of iron deposits. This suggested that there was an active and prolonged inflammatory process associated with chronic iron deposition within infarcted territories. Figure 6B ).
Mass Spectrometry ICP-MS data showed that the mean iron content in
Morphological and Functional Characteristics of LV in Canines After I/R Injury
Consistent with the patient studies, LV mass index, %Infarct volume, and %Hemo volume decreased significantly between acute (day 3) and chronic (day 56) phases postreperfusion ( Consistent with the patient studies, multivariable regression analysis showed that both %Infarct volume and %Hemo volume measured at 3 days postreperfusion were significant predictors of percentage change in EDSI between acute and chronic phases (%Infarct volume: β=0.81, P=0.014; %Hemo volume: β=1.82, P=0.034). Simple regression analysis showed that %Hemo volume measured at 56 days postreperfusion is a significant predictor of percentage change in EDSI between acute and chronic phases (β=2.82; P=0.031). However, a separate multivariable regression analysis showed that only %Infarct volume measured at 56 days postreperfusion was a significant predictor of percentage change in EDSI between acute and chronic phases (β=0.76; P=0.039). However, neither %Infarct volume nor %Hemo volume measured at Figure 2 . Cardiovascular magnetic resonance (CMR) for detecting chronic iron deposition after hemorrhagic myocardial infarctions in a canine model. Representative CMR images (T2* and late gadolinium enhancement [LGE]) obtained during acute and chronic phases from a canine subjected to reperfused hemorrhagic myocardial infarction along the long and short axes (along the dashed red line in the long-axis images), together with corresponding ex vivo images, are shown. In vivo T2* images (both acute and chronic phases) clearly demonstrate the evidence of signal loss in the left anterior descending artery territory (arrows), where the hemorrhagic infarctions were expected to occur. Arrows in LGE images point to the site of infarction. Note that the short-axis images are T2* maps (color coded), and the corresponding long-axis T2* images are T2*-weighted (echo time=18 milliseconds). .03) . B, Mean ex vivo T2* of Hemo+ infarct sections was significantly lower than those of shams, remote, and Hemo− (*P<0.001). C, Linear regression analysis between in vivo T2* heart (acute and chronic) and ex vivo T2* heart showed strong correlations, indicating that ex vivo T2* provides a reasonable estimate of in vivo T2* heart . both 3 days and 56 days postreperfusion could significantly predict changes in other LV remodeling parameters (EDV, ESV, and EF).
Discussion
To date, the specific long-term consequence of hemorrhagic transformation of myocardial infarction in humans is unknown. Using clinical T2* CMR, we investigated whether patients suspected of having hemorrhagic myocardial infarctions were disposed to regional iron depositions within the myocardial scar months after the infarction. Supported by the validation studies in canines, in a pilot investigation, we demonstrated that chronic iron deposition could take place in humans after acute hemorrhagic myocardial infarctions. Mass spectrometric analysis of canine myocardial tissue showed the mean iron content within the hemorrhagic infarctions to be nearly an order of magnitude greater in a chronic phase (8 weeks) after infarction compared with remote/healthy and nonhemorrhagic myocardium. In relating the mass spectrometric findings to ex vivo CMR, our noninvasive imaging studies showed that T2* CMR can detect and quantify the extent of iron deposition within chronic hemorrhagic myocardial infarctions. These observations also provided a firm basis for noninvasively characterizing chronic iron depositions after acute hemorrhagic infarctions in canines in vivo. Volumetric CMR data from both patients and canines showed that both relative infarct and hemorrhage volume in the acute phase were significant predictors of LV remodeling on the basis of sphericity index in the chronic period after infarction. In addition, immunohistological staining for newly recruited macrophages showed an ongoing inflammatory response in the infarct tissue with iron deposits in the chronic phase of hemorrhagic infarctions.
Detection of Regional Iron Deposition After Hemorrhagic Infarctions
Current knowledge of pathological iron deposition in the heart has been limited to global iron overloading in the heart attributable to hematologic disorders, such as thalassemia, hemochromatosis, and sickle-cell anemia. In a number of these settings, T2* CMR has been shown to be invaluable for quantifying the global extent of iron in the heart. In particular, a recent study clearly demonstrated that the magnitude of T2* is strongly correlated with the amount of iron deposition (measured on the basis of ICP-MS) in postmortem hearts of deceased thalassemia patients. 11 To date, however, there has been no direct evidence of significant localized deposition of iron in the heart. In this study, we identified reperfused hemorrhagic myocardial infarctions as the basis for a new pathogenesis associated with highly localized iron deposition in the heart that can be characterized on the basis of T2* CMR. Our findings are consistent with previous observations of the deposition of iron in other organs in the form of hemosiderin (magnetite, crystalline Fe 3 O 4 particles) after the biodegradation of RBCs 1,2 that are also detected on the basis of T2* MRI. Both T2*-weighted and T2-weighted CMR techniques have been used to detect acute reperfusion intramyocardial hemorrhage. [31] [32] [33] [34] [35] [36] 38, 39, 43 After intramyocardial hemorrhage, oxyhemoglobin in the RBCs extravasated into the myocardial interstitium is slowly converted into paramagnetic forms, such as deoxyhemoglobin and methemoglobin, in the acute phase of myocardial infarction. 1 Our current study has shown that, in the chronic phase of infarction (ie, months after infarction), iron from the extravasated RBCs is externalized and crystallized to form the highly paramagnetic hemosiderin deposits. These paramagnetic agents induce local magnetic field inhomogenities that appear as hypointense territories on both T2*-weighted and T2-weighted images. 45, 46 In the acute phase of infarction, T2-weighted techniques are also highly sensitive to elevated free water content arising from myocardial edema. Myocardial edema is a standard pathophysiological consequence of acute I/R injury that seems hyperintense on T2-weighted images. Previous studies have shown that the counteracting effects of the hyperintense myocardial edema and hypointense myocardial hemorrhage in T2-weighted images can indeed obscure the detection of hemorrhage. 47 Therefore, absolute characterization of intramyocardial hemorrhage using T2-weighted techniques may be complicated by the confounding effects of edema. In contrast, T2*-weighted techniques are relatively less sensitive to edema, making them highly sensitive to the paramagnetic effects of hemorrhage. For this reason, we chose to use a T2* mapping approach in our study to accurately characterize both acute reperfusion hemorrhage and the ensuing chronic iron depositions.
Although T2*-CMR is highly sensitive to chronic myocardial iron depositions within the infarcted territories, it is also sensitive to the magnetic susceptibility differences at the heart-lung interface (off-resonance artifacts) that manifest as hypointense regions in the inferolateral walls. Therefore, offresonance artifacts occurring in the inferolateral walls may be misinterpreted as hemorrhagic infarctions. However, it is possible to distinguish hemorrhage from the off-resonance artifacts because hemorrhage originates in the subendocardium and is limited to the infarcted myocardium, whereas off-resonance artifacts originate at the epicardium. 39 In this study, offresonance artifacts were easily identified in both patients and canines, and did not limit our ability to identify hemorrhage.
Long-term Consequences of Regional Iron Deposition Within Infarcted Myocardium
The pathological consequence of regional iron deposition in the chronic phase of the hemorrhagic infarctions was also unknown before this study. In our study, immunohistochemical staining with Mac387 showed that infiltration of young macrophages is preferentially enhanced at the site of iron deposition within chronic infarcts, with minimal or no macrophages within the infarcted territories without iron. The monoclonal antibody Mac387 detects the calcium-binding protein MRP14 that is selectively expressed by young macrophages (<7 days old) newly recruited from peripheral blood monocytes, but not mature tissue macrophages. 48 , 49 Frangogiannis et al 50 have used Mac387 to index for active inflammatory process in the heart. They showed that Mac387-positive cells extensively infiltrate the infarcted territories within 1 hour of I/R injury, but very few Mac387-positive cells are found after 7 days of I/R injury. Hence, our data findings here suggest that chronic iron deposition after acute reperfusion intramyocardial hemorrhage leads to an active and prolonged inflammatory process. The selective recruitment of Mac387-positive cells to the zones of chronic iron deposition within infarcted territories may be one of the potential mechanisms through which hemorrhagic infarctions lead to adverse LV remodeling. Nevertheless, additional studies are necessary to understand the relation between long-term inflammation in the presence of iron deposition and cardiac remodeling.
Iron deposition within infarcted myocardium has also been reported in the setting of iron-labeled regenerative cell therapies. 51 It was shown that when iron-labeled stem cells are delivered to the site of infarction, even after a few weeks of delivery, the iron particulates (label) continue to persist at the site of infarction. However, the iron labels were colocalized within macrophages instead of the stem cells, suggesting that once the transplanted cells perished, the macrophages are drawn to the site of remnant iron particulates. Our data, along with the previous reports, 51 suggest that macrophages are drawn to the site of iron regardless of its origin (endogenous or exogenous). Previous studies have also suggested that iron particulates mediate activation of microglia in the brain 52 and differentiation of blood mononuclear cells into proinflammatory macrophages. 53 Moreover, hemoglobin-derived iron in combination with activated macrophages has been shown to generate reactive oxygen species in chondrocytes. 54 Although these observations have not been extended into myocardial tissue, the highly selective recruitment of young macrophages at the site of iron deposition suggests that the mechanism of macrophages recruitment to the site of chronic infarction may be similar. Because T2* of hemorrhagic infarcts seems to be stable between acute and chronic phases in both animals and patients, it seems that iron depositions from hemorrhagic infarctions are at best only slowly cleared by the macrophages. Additional studies are necessary to investigate the temporal dynamics of macrophage-based clearance of iron within infarcts. From our imaging studies in humans, it seems that the clearance takes >6 months, given that at the 6-month follow-up, significant T2* shortening was evident at the site of hemorrhagic infarction compared with nonhemorrhagic infarct territories or remote/healthy myocardium. Because T2* data were significantly correlated with direct measurements of iron in tissue (mass spectrometry analysis), clinical T2* CMR is well positioned for the assessment of changes in iron deposition in the postinfarction period.
Although our study was not performed with the goal of determining the effect of hemorrhagic infarcts on morphological or functional changes of LV, an important detail on LV remodeling emerged from this study. Our data showed that in both humans and animals with hemorrhagic infarction, LV remodeling (indexed on the basis of EDSI) between the acute and chronic phases of the infarction was significantly impacted by %Infarct and hemorrhage volume. Although the effect of infarct size on LV remodeling has been well known, 55 our study showed that hemorrhage volume is a strong predictor of EDSI as well. In fact, the respective β coefficients from multivariable regression analyses further suggest that the percent hemorrhage (%Hemo) volume in the acute phase, in both humans and canines, has a greater influence on EDSI (β=2.02 [humans] and β=1.82 [canines]) than infarct volume in the acute phase (β=1.59 [humans] and β= 0.8 [canines]). Nevertheless, other LV remodeling parameters, such as EF, EDV, and ESV, did not reach statistical significance to show dependence on %Infarct or %Hemo volume. Further studies supported by larger sample sizes are expected to be necessary to resolve these differences.
Limitations
This study has certain limitations. First, our definition of hemorrhagic myocardium as the infarcted regions with low signal intensity on T2*-weighted images itself implies that the T2* values of hemorrhagic myocardium are significantly lower than those of other tissues. Nevertheless, Perls staining and mass spectrometry clearly validated that hemorrhagic myocardium, defined on the basis of low T2* values, had significantly higher iron depositions. We also showed that infarctions with low T2* values in the acute phase had concomitantly low T2* values in the chronic phase, as well.
Second, the sample size in this study was small, which may have limited the modest differences from being detected because of insufficient power. Although this could partly explain why the impact of %Infarct or %Hemo volumes on commonly reported LV remodeling parameters, such as EDV, ESV, and EF, could not be detected, we were still able to discern a relationship between %infarct and %Hemo volume on EDSI. Moreover, further studies are necessary to evaluate the relative effects of MVO and hemorrhage on postinfarction LV remodeling. Third, the infarction in animals was only created in the left anterior descending artery territory. Although we expect our results to hold independently of the territory of hemorrhagic infarction, additional studies are necessary to confirm whether our findings can be extended to all territories of the myocardium.
Finally, although we were able to validate our findings of iron deposition within hemorrhagic infarcts in animals on the basis of histological and mass spectrometry analysis, the evidence for iron deposition in patients with hemorrhagic infarctions is only based on T2* CMR. Nevertheless, because the CMR results between animals and patients were consistent, and because chronic iron deposition after hemorrhagic infarctions showed significant correlation against T2* CMR in animals, we anticipate that T2* CMR is a reliable alternative for the assessment of iron deposition in patients. Similarly, histopathologic findings of prolonged inflammation are limited only to hemorrhagic infarctions in canines. Additional histopathologic and mass spectrometric analyses of human hearts with chronic hemorrhagic infarctions may be necessary to rigorously extend these findings to humans.
Conclusion
Hemorrhagic myocardial infarction can lead to iron depositions within the infarct zones, which can be a source of prolonged inflammatory burden in chronic phase of myocardial infarction.
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